health_and_safety
PCOS Copilot
settings
HIPAA EXPORT

Clinical Doctor Summary

Validated clinical summary compiled for your next consultation with an endocrinologist or gynecologist.

Reporting Period

Oct 01, 2023 - Jan 01, 2024

Phenotype Analysis

Type C (Ovulatory PCOS)

Last Lab Update

Dec 14, 2023

analyticsSymptom Prevalence & Severity

face

Hirsutism / Acne

Androgen sensitivity indicators

Severe (82%)

battery_very_low

Fatigue / Brain Fog

Metabolic/Inflammatory link

Moderate (45%)

psychology

Mood Swings / Anxiety

Progesterone deficiency related

Moderate (56%)

calendar_monthCycle History

Avg Cycle Length42 Days
Period Variation+/- 8 Days
Flow IntensityHeavy (Clotted)

warningCLINICAL ALERT

Patient reports secondary amenorrhea lasting 55 days in current cycle.

biotechHormonal & Lab Markers

LH/FSH RATIO

3.2:1High

Indicates possible follicular recruitment issue

TESTOSTERONE

78 ng/dLElevated

Free Androgen Index: 9.4%

FASTING INSULIN

14.2 µU/mLBorderline

HOMA-IR: 3.1 (Resistance Likely)

VITAMIN D3

22 ng/mLLow

Recommend 5000 IU/day titration

show_chartWeight & BMI Trend

90 Days

Current Weight

74.2 kg (-2.4kg)

BMI Index

26.4 Overweight

clinical_notesClinical Recommendations

  • 1

    Consider Inositol (4g/day) or clinical titration to address HOMA-IR of 3.1 and borderline fasting insulin levels.

  • 2

    Pelvic Ultrasound is recommended to validate polycystic ovarian morphology given elevated LH/FSH ratio and oligomenorrhea.

  • 3

    Serum DHEAS and 17-OHP labs are suggested to rule out late-onset NCAH given clinical androgen symptoms.

This document represents raw clinical intelligence generated dynamically by Oviora PCOS Copilot. All data is processed using secure, HIPAA-compliant methodologies.